3-[(4-Bromo-2,6-difluorophenyl)methoxy]-5-[[[[4-(1-pyrrolidinyl)butyl]amino]carbonyl]amino]-4-isothiazolecarboxamide (CP-547632)

potent inhibitor of the VEGFR-2 and basic fibroblast growth factor (FGF) kinases (IC₅₀ = 11 and 9 nM, respectively). It is selective relative to epidermal growth factor receptor, platelet-derived growth factor ß, and other related TKs. It also inhibits VEGF-stimulated autophosphorylation of VEGFR-2 in a whole cell assay with an IC₅₀ value of 6 nM

OTAVAchemicals Catalogue Number: 1156353

CAS Registry Number: 252003-65-9

Purity: 95%+ (HPLC)

Ref.: Beebe et al. Pharmacological Characterization of CP-547,632, a Novel Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for Cancer Therapy. Cancer Research (2003), 63, 7301-7309

Abstract: CP-547,632 is a well-tolerated, orally-bioavailable inhibitor presently under clinical investigation for the treatment of human malignancies.

http://cancerres.aacrjournals.org/cgi/reprint/63/21/7301.pdf

Need more information regarding this product? Send us an inquiry: Name: * First Last Company: * E-mail: (if you do not receive a response within 24 hours, please check your email spam folder, as it may have been blocked by your spam filter) * Please specify name of the product: * Word Verification: type_submit_reset_7 SubmitReset